U.S. Food & Drug Administration
Obtaining maximum information about hepatitis C quasispecies discussed
Published in Lab Business Week, April 3rd, 2005
According to published research from the United States, "Most studies of hepatitis C virus (HCV) quasispecies have reported the results of sequencing only three to five clones per sample. The possibility that sequencing so few clones might not provide a representative picture of the quasispecies present in a sample has never been evaluated. The present study was conducted to evaluate whether sequencing greater numbers of clones results in better information about the HCV quasispecies number and distribution, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-04-03)
More Articles from Lab Business Week
- Abeille Pharmaceuticals, Inc.
Pharmaceutical firm completes $1M financing - Abgenix, Inc.
Biotech company reports loss of $0.48 per share - Acadia Pharmaceuticals, Inc.
Pharmaceutical company reports loss of $7.3M - Advanced Neuromodulation Systems
Medical device firm reports record 4Q, 2004 neuro sales increased 36% - Akorn, Inc.
Pharmaceutical firm reports net sales of $12.6M - Albany Molecular Research, Inc.
Drug discovery firm reports 11% decrease in fourth quarter revenue - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
